{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "Organization",
      "@id": "https://rhizen.com/#organization",
      "name": "Rhizen – Pharmaceuticals AG",
      "url": "https://rhizen.com/",
      "description": "--> --> --> Rhizen – Pharmaceuticals AG Home About Us The Rhizen Journey Leadership Team What We Do Our Science Our Pipeline Partnering Partnering Strategy Our Partners News and Events From the Director’s Desk Latest News Recent Publications Contact Us Innovative Medicines Developing next generation medicines that will lead the fight against cancer & inflammation Our Highlights Tenalisib- a Phase 2 study in metastatic TNBC patients, post-adjuvant in progress. RP12146 – a Phase 1 B expansion study in mCRPC is in progress. Relentless and innovative thinking that keeps our science one step ahead, always!"
    },
    {
      "@type": "WebPage",
      "@id": "https://directory.websdocs.com/business/rhizen-and-8211-pharmaceuticals-ag#asg",
      "name": "Rhizen – Pharmaceuticals AG ASG Directory Profile",
      "url": "https://directory.websdocs.com/business/rhizen-and-8211-pharmaceuticals-ag",
      "isPartOf": {
        "@id": "https://rhizen.com/#organization"
      },
      "description": "Public business information published by the WebsDocs ASG Directory."
    }
  ]
}